CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: A Phase 2 Trial of OPC-64005 for Major Depressive Disorder [Phase 2]
Summary
Phase 2 trial of OPC-64005 for major depressive disorder has completed and results have been posted (September 2024).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19